The Journal of antimicrobial chemotherapy · 2012
High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Buied A, Moore C B, Denning D W, Bowyer P
Аннотация
OBJECTIVES: Resistance to azole antifungal drugs in Aspergillus fumigatus that is not mediated by target gene mutations is now common in some locations. The aim of this study was to investigate possible new mechanisms of resistance in non-target resistance.
METHODS: Twelve azole-resistant A. fumigatus isolates previously shown not to carry mutations in cyp51A were tested to determine whether the alternative cyp51B gene was overexpressed.
RESULTS: Of 12 isolates one showed overinduction of cyp51B after exposure to itraconazole and another showed high constitutive expression of cyp51B.
CONCLUSIONS: cyp51B overexpression is a possible azole resistance mechanism in A. fumigatus.
METHODS: Twelve azole-resistant A. fumigatus isolates previously shown not to carry mutations in cyp51A were tested to determine whether the alternative cyp51B gene was overexpressed.
RESULTS: Of 12 isolates one showed overinduction of cyp51B after exposure to itraconazole and another showed high constitutive expression of cyp51B.
CONCLUSIONS: cyp51B overexpression is a possible azole resistance mechanism in A. fumigatus.